ITP in Dogs: Immune Thrombocytopenia Signs, Treatment & Recovery

Last updated: May 6, 2026

Discovering unexplained bruises on your dog’s belly, tiny red dots scattered across the gums, or a sudden nosebleed that will not stop is alarming for any pet owner. These signs may point to a serious blood disorder called immune thrombocytopenia, commonly referred to as ITP. ITP in dogs occurs when the immune system mistakenly targets and destroys the body’s own platelets — the tiny blood cells responsible for clotting. Without enough platelets circulating in the bloodstream, even minor bumps or normal blood vessel wear and tear can lead to visible and sometimes dangerous bleeding.

While a diagnosis of ITP can feel overwhelming, the condition is well-recognized in veterinary medicine, and many dogs respond favorably to treatment. Understanding how the disease works, what symptoms to watch for, and what treatment options are available gives owners the best chance of helping their dog through this challenging condition and into recovery.

What Is ITP in Dogs?

Immune thrombocytopenia, also known as immune-mediated thrombocytopenia or IMT, is a condition in which the dog’s immune system produces antibodies that attach to platelets and mark them for destruction. Platelets, also called thrombocytes, are small cell fragments produced in the bone marrow that play a critical role in hemostasis — the process of stopping bleeding. When a blood vessel is damaged, platelets rush to the site, clump together, and form a temporary plug that prevents blood loss while the vessel heals.

A healthy dog typically has a platelet count between 175,000 and 500,000 platelets per microliter of blood. Dogs with ITP in dogs often present with platelet counts below 40,000, and in severe cases the count can drop below 10,000 — a level at which spontaneous, life-threatening bleeding becomes a real possibility. The condition is one of the most common immune-mediated diseases seen in dogs and accounts for a significant proportion of cases involving severe thrombocytopenia in veterinary emergency rooms.

ITP is classified as either primary or secondary. Primary ITP, which makes up the majority of cases, occurs when the immune system attacks platelets for no identifiable underlying reason — it is an autoimmune process without a clear trigger. Secondary ITP occurs when platelet destruction is set off by an identifiable cause such as an infection (tick-borne diseases like ehrlichiosis or babesiosis are common culprits), certain medications (sulfonamide antibiotics, for example), cancer, or vaccination. Identifying whether a case is primary or secondary is important because secondary ITP will not resolve fully unless the underlying trigger is also addressed.

How Platelets Are Destroyed in ITP

Understanding the mechanism behind ITP in dogs helps explain why the condition can develop so rapidly and why treatment focuses on suppressing the immune system rather than simply replacing lost platelets.

In a dog with ITP, the immune system produces immunoglobulin G (IgG) antibodies that bind to proteins on the surface of circulating platelets. These antibody-coated platelets are then recognized as foreign or damaged by macrophages — a type of white blood cell whose job is to engulf and destroy abnormal cells. The spleen is the primary organ where this destruction takes place, acting as a filter that traps the antibody-tagged platelets and removes them from circulation. The liver also plays a role in platelet clearance.

Under normal circumstances, the bone marrow ramps up platelet production to compensate when platelet numbers drop. In many dogs with ITP, the bone marrow does respond appropriately, producing large numbers of young platelets called megakaryocytes. However, the rate of immune-mediated destruction far outpaces the bone marrow’s ability to replace them, resulting in a net loss that drives the platelet count steadily downward. In some cases, the antibodies may also target megakaryocytes within the bone marrow itself, impairing production at the source and making the thrombocytopenia even more severe.

This rapid destruction is why platelet counts can plummet seemingly overnight. An owner may notice their dog acting perfectly fine one day and presenting with widespread bruising the next. The speed of onset is one of the hallmarks of immune-mediated platelet destruction.

Symptoms of ITP in Dogs

The clinical signs of ITP in dogs are directly related to the loss of the body’s clotting ability. Symptoms can range from subtle and easy to miss to dramatic and immediately life-threatening, depending on how low the platelet count has fallen.

Petechiae. One of the earliest and most characteristic signs is the appearance of petechiae — tiny, pinpoint-sized red or purple dots on the skin, gums, inner ear flaps, or the whites of the eyes. These dots represent small bleeds occurring in the capillaries just beneath the surface. Petechiae are easiest to see on areas with less fur and lighter pigment, such as the belly, inner thighs, and gum line. Many owners first notice them during belly rubs or while brushing their dog’s teeth.

Bruising (ecchymoses). As platelet counts drop further, larger areas of discoloration may appear on the skin. These bruises often show up on the abdomen, groin, or inner legs and can appear without any obvious trauma. Unlike bruising from an injury, ITP-related bruising tends to involve multiple sites and may seem to spread or multiply over a short period of time.

Nosebleeds (epistaxis). Spontaneous bleeding from the nose is another common symptom. The nosebleed may be mild — a few drops noticed on bedding or the floor — or heavy and difficult to stop. Some dogs experience bleeding from one nostril while others bleed from both. Nosebleeds that persist for more than a few minutes or recur frequently should be investigated promptly.

Bloody stool or urine. Blood may appear in the stool (as fresh red blood or as dark, tarry stool called melena) or in the urine (hematuria). Some owners notice blood-tinged vomit as well. Internal bleeding in the gastrointestinal tract can occur even when external signs are mild, making these symptoms especially important to recognize.

Bleeding from the gums. The gums may bleed spontaneously or with minimal contact, such as when the dog chews on a toy or eats hard kibble. The gums may also appear pale if significant blood loss has occurred, indicating anemia.

Lethargy and weakness. Dogs with severe thrombocytopenia or secondary anemia from blood loss often become noticeably lethargic. They may be reluctant to walk, play, or eat. In advanced cases, weakness can progress to collapse.

Excessive bleeding from minor wounds. A small cut, a nail trim, or a routine blood draw may result in prolonged bleeding that is difficult to stop — often the first clinical clue that something is wrong with the clotting system.

Diagnosing ITP in Dogs

When a veterinarian suspects ITP in dogs, diagnosis involves a combination of blood work, physical examination findings, and sometimes more advanced testing to rule out other causes of low platelet counts.

Complete blood count (CBC). The most important initial test is a complete blood count, which reveals the platelet number. A severely low platelet count — often below 20,000 to 40,000 per microliter — combined with clinical bleeding signs raises immediate suspicion for ITP. The CBC also shows whether anemia is present (from blood loss or concurrent immune-mediated destruction of red blood cells) and whether white blood cell counts are abnormal.

Blood smear examination. A manual review of a blood smear under the microscope allows the veterinarian to confirm the low platelet count, look for platelet clumping (which can falsely lower automated counts), assess platelet size (large platelets suggest the bone marrow is actively trying to compensate), and check red blood cell shape for signs of concurrent disease.

Coagulation panel. Tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) help differentiate ITP from other clotting disorders. In pure ITP, these coagulation times are typically normal because the clotting factor cascade is not affected — only the platelet component is deficient.

Tick-borne disease screening. Because infections like ehrlichiosis, anaplasmosis, and Rocky Mountain spotted fever are common causes of secondary thrombocytopenia, most veterinarians will run a tick panel (such as a SNAP 4Dx test) as part of the workup. Identifying and treating an underlying tick-borne infection can be curative in cases of secondary ITP.

Bone marrow biopsy or aspirate. In cases where the diagnosis is unclear, the platelet count does not respond to initial treatment, or the veterinarian suspects that megakaryocyte production in the bone marrow may be compromised, a bone marrow biopsy may be recommended. In most dogs with primary ITP, the bone marrow shows increased numbers of megakaryocytes — evidence that the marrow is working overtime to produce platelets that are being destroyed as fast as they are released. If the bone marrow shows decreased or absent megakaryocytes, other diagnoses such as bone marrow disease or aplastic conditions must be considered.

Additional testing. Depending on the dog’s age, history, and physical examination findings, the veterinarian may also recommend abdominal ultrasound, chest radiographs, urinalysis, or advanced immunologic testing to rule out underlying cancers, infections, or concurrent autoimmune diseases.

Treatment of ITP in Dogs

Treatment for ITP in dogs centers on suppressing the immune system’s attack on platelets and managing any complications from bleeding. The approach is often aggressive initially, with the goal of raising the platelet count as quickly as possible to reduce the risk of fatal hemorrhage.

Corticosteroids. The cornerstone of ITP treatment is high-dose corticosteroid therapy, most commonly prednisone or dexamethasone. Steroids work by broadly suppressing immune function, reducing antibody production, and decreasing the ability of macrophages in the spleen to destroy antibody-coated platelets. Most dogs are started on immunosuppressive doses of prednisone (typically 2 mg/kg per day or higher), and many show a measurable increase in platelet count within three to seven days. Once the platelet count stabilizes in the normal range, the steroid dose is tapered gradually over weeks to months. Tapering too quickly is one of the most common causes of relapse.

Additional immunosuppressant medications. When steroids alone are insufficient, when the disease is severe at presentation, or when steroid side effects (excessive thirst, urination, weight gain, panting) are intolerable, a second immunosuppressant drug is often added. Common choices include azathioprine, mycophenolate mofetil, cyclosporine, and leflunomide. These drugs work through different mechanisms to further suppress the immune response and allow for lower steroid doses. They typically take one to three weeks to reach full effect, so they are usually started alongside steroids rather than as replacements.

Vincristine. In emergency situations where the platelet count is critically low and the dog is actively bleeding, vincristine — a chemotherapy agent — may be administered as a single intravenous dose. Vincristine can cause a rapid but temporary increase in platelet count by stimulating platelet release from the bone marrow and potentially interfering with macrophage function. It is not a long-term treatment but can serve as a bridge to buy time while immunosuppressive medications take effect.

Platelet Transfusions and Blood Products

Platelet transfusions are sometimes considered in dogs with life-threatening bleeding, but they present a significant limitation in ITP: because the immune system is actively destroying platelets, transfused platelets are also destroyed rapidly, often within hours. For this reason, platelet transfusions are generally reserved for emergencies where the dog is hemorrhaging and needs temporary clotting support while immunosuppressive therapy begins to work.

Fresh whole blood transfusions or packed red blood cell transfusions may be necessary if the dog has developed significant anemia from blood loss. These transfusions address the anemia rather than the platelet deficiency itself and can be life-saving in dogs that have bled heavily into the gastrointestinal tract, urinary tract, or body cavities.

Human intravenous immunoglobulin (hIVIG) is another option used in some veterinary emergency settings. It works by temporarily blocking the receptors on macrophages, slowing platelet destruction and allowing the platelet count to rise. It is expensive and not universally available, but it can provide rapid improvement in critical cases.

Splenectomy as a Treatment Option

Because the spleen is the primary site of platelet destruction in ITP in dogs, surgical removal of the spleen (splenectomy) is sometimes considered in dogs that fail to respond to medical therapy or that relapse repeatedly despite appropriate immunosuppressive treatment.

Splenectomy removes the main organ responsible for filtering and destroying antibody-coated platelets, which can lead to sustained improvement in platelet counts in some dogs. Studies suggest that splenectomy produces a favorable response in approximately 30 to 60 percent of dogs with refractory ITP, though results vary and the procedure carries surgical risk — particularly in a dog with impaired clotting ability.

The decision to pursue splenectomy is not taken lightly. It is typically reserved for dogs that have failed at least two immunosuppressive protocols and continue to have dangerously low platelet counts or frequent relapses. Dogs that undergo splenectomy may still require some level of immunosuppressive medication afterward, though often at reduced doses.

Evans Syndrome: When ITP and IMHA Occur Together

In some dogs, immune-mediated thrombocytopenia occurs simultaneously with immune-mediated hemolytic anemia (IMHA) — a condition in which the immune system also destroys red blood cells. This combination is known as Evans syndrome, and it represents a more severe and complex form of autoimmune disease.

Dogs with Evans syndrome face a dual threat: they are losing both the cells needed for clotting (platelets) and the cells needed for oxygen transport (red blood cells). Symptoms include all the bleeding signs of ITP plus the signs of anemia — pale or yellow-tinged gums (jaundice from red blood cell breakdown), rapid breathing, elevated heart rate, dark-colored urine, and profound weakness.

Evans syndrome carries a more guarded prognosis than ITP alone. Treatment is similar but typically more aggressive, often requiring multiple immunosuppressive drugs, blood transfusions for the anemia, and intensive monitoring. Despite the challenges, many dogs with Evans syndrome can be stabilized and managed successfully with committed veterinary care.

Prognosis and Recovery

The prognosis for ITP in dogs is generally favorable when the condition is diagnosed promptly and treated aggressively. Studies report survival rates of approximately 70 to 90 percent for dogs that receive appropriate immunosuppressive therapy and survive the initial critical period — the first few days of treatment when platelet counts are at their lowest and bleeding risk is highest.

Most dogs show a measurable increase in platelet count within three to seven days of starting treatment, with counts often returning to normal within one to two weeks. Once the platelet count has stabilized, medications are tapered slowly — often over three to six months — to find the lowest effective dose that keeps the immune system in check without causing excessive side effects.

Some dogs achieve complete remission and can eventually be weaned off all medications. Others require low-dose, long-term immunosuppressive therapy to maintain stable platelet counts. The duration of treatment depends on the severity of the initial episode, how quickly the dog responded, and whether relapses occur during tapering.

Negative prognostic indicators include very low platelet counts at presentation (below 5,000), concurrent Evans syndrome, melena or signs of significant internal bleeding, older age at diagnosis, and failure to respond to initial steroid therapy within the first week.

Relapse: What to Watch For

One of the frustrating realities of ITP is that relapse is relatively common. Studies estimate that 20 to 50 percent of dogs with primary ITP will experience at least one relapse, sometimes months or even years after the initial episode. Relapses may occur during medication tapering, after medications are discontinued, or during periods of physiological stress such as surgery, illness, or vaccination.

Owners of dogs with a history of ITP in dogs should remain vigilant for the return of symptoms: new petechiae, unexplained bruising, nosebleeds, bloody stool, or renewed lethargy. Early detection of a relapse allows treatment to resume before the platelet count drops to dangerous levels, which generally leads to faster and easier resolution than the initial episode.

Regular veterinary check-ups that include complete blood counts are important during and after treatment, both to monitor for relapse and to guide medication adjustments. Many veterinarians recommend rechecking platelet counts every one to two weeks during active treatment and tapering, then every few months once medications are discontinued.

Breeds at Risk for ITP

While any dog can develop ITP, certain breeds appear to be predisposed, suggesting a genetic component to immune dysregulation. Breeds that are reported more frequently in studies of ITP in dogs include Cocker Spaniels, Old English Sheepdogs, German Shepherds, Poodles (particularly Standard Poodles), Labrador Retrievers, and Golden Retrievers. Mixed-breed dogs also develop the condition and should not be overlooked in differential diagnosis. You can learn more about specific breed health profiles in our dog breeds directory.

Female dogs are affected more often than males, a pattern consistent with many autoimmune conditions in both dogs and humans. Most dogs are diagnosed between three and eight years of age, though ITP can occur in dogs of any age.

If you are considering adding a dog to your family, understanding breed-specific health risks is an important part of responsible pet ownership. Adopting a dog from a shelter or rescue gives animals a second chance, and shelter staff can often share available health history to help you prepare for potential breed-related conditions.

Living with a Dog After an ITP Diagnosis

Managing life after an ITP diagnosis involves a combination of medication compliance, regular monitoring, and practical adjustments at home. During active treatment and recovery, owners should minimize the risk of injury by avoiding rough play, keeping the dog on leash during walks, and providing soft bedding. Hard chew toys should be replaced with softer alternatives to reduce the risk of gum bleeding.

Steroid side effects — particularly increased thirst, appetite, and urination — can be significant during the high-dose phase of treatment and may require management with more frequent bathroom breaks and careful weight monitoring. These side effects generally improve as the steroid dose is tapered.

Owners should discuss vaccination protocols with their veterinarian, as some dogs with a history of immune-mediated disease may benefit from modified or reduced vaccination schedules. This does not mean skipping all vaccines, but rather making informed decisions about which vaccines are essential and timing them carefully.

With consistent care, regular blood monitoring, and a strong partnership between owner and veterinarian, most dogs with ITP go on to live comfortable, happy lives — and many never experience a second episode.

Frequently Asked Questions

Is ITP in dogs fatal?

ITP can be fatal if left untreated, particularly if severe bleeding occurs in the brain, lungs, or gastrointestinal tract. However, with prompt diagnosis and aggressive immunosuppressive treatment, the majority of dogs — approximately 70 to 90 percent — survive and recover well. The most dangerous period is the first few days before treatment takes effect.

How long does it take for a dog to recover from ITP?

Most dogs show improvement in platelet counts within three to seven days of starting treatment. Full stabilization typically occurs within two to four weeks. However, medication tapering takes three to six months or longer, and some dogs require ongoing low-dose therapy. Complete recovery, including medication discontinuation, may take six months to over a year.

Can ITP in dogs be caused by vaccines?

In rare cases, vaccination has been associated with triggering ITP, typically within a few weeks of administration. This is an example of secondary ITP. While the overall risk is very low, dogs with a prior history of ITP should have their vaccination schedule carefully evaluated by their veterinarian to weigh the benefits against potential risks.

What is the difference between ITP and IMHA in dogs?

ITP involves immune-mediated destruction of platelets (clotting cells), while IMHA involves immune-mediated destruction of red blood cells (oxygen-carrying cells). ITP causes bleeding problems; IMHA causes anemia. When both conditions occur together, it is called Evans syndrome. Both are autoimmune conditions that require immunosuppressive treatment.

Can I adopt a dog with ITP?

Yes. Many dogs with a history of ITP live normal, happy lives after treatment. If you are considering adoption, ask the rescue or shelter about the dog’s medical history, current medications, and ongoing monitoring needs. Dogs in remission from ITP can make wonderful companions with proper veterinary follow-up.

Does ITP in dogs always come back?

Not always, but relapse is a recognized possibility. Approximately 20 to 50 percent of dogs experience at least one relapse. Some dogs achieve permanent remission after a single episode and never relapse. Careful medication tapering, regular blood work, and close monitoring reduce the risk and help catch relapses early.